Muscarinic receptor alterations following neostigmine treatment
- 1 May 1982
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 80 (2-3), 275-278
- https://doi.org/10.1016/0014-2999(82)90069-3
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Decreased muscarinic binding sites in small intestine from mice treated with neostigmineLife Sciences, 1981
- Reduced 63H9quinuclidinyl benzilate binding to muscarinic receptors in disulfoton-tolerant mice*1Toxicology and Applied Pharmacology, 1981
- Tolerance to neostigmine in rodents and its prevention by cycloheximide treatmentJournal of Pharmacy and Pharmacology, 1978
- Acetylcholine and choline in mouse brain—Influence of peripherally acting cholinergic drugsBiochemical Pharmacology, 1977
- BINDING CHARACTERISTICS OF A RADIOLABELED AGONIST AND ANTAGONIST AT CENTRAL NERVOUS-SYSTEM ALPHA NORADRENERGIC RECEPTORS1977
- BETA-ADRENERGIC RECEPTOR-BINDING IN MEMBRANE PREPARATIONS FROM MAMMALIAN BRAIN1976
- Comparative toxicity, anticholinesterase action and metabolism of methyl parathion and parathion in sunfish and miceToxicology and Applied Pharmacology, 1974
- Influence of chronic neostigmine treatment on the number of acetylcholine receptors and the release of acetylcholine from the rat diaphragmThe Journal of Physiology, 1973
- SYNDROMES SIMULATING MYASTHENIA GRAVIS: ASTHENIA WITH ANTICHOLINESTERASE TOLERANCEAnnals of the New York Academy of Sciences, 1966